DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
CD34+ Peripheral Blood Stem Cell Reinfusion ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
49
全身性エリテマトーデス
1
49. 全身性エリテマトーデス
臨床試験数
:
946
/
薬物数
:
722
- (
DrugBank
:
186
) /
標的遺伝子数
:
117
-
標的パスウェイ数
:
199
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00017641
(
ClinicalTrials.gov
)
April 2001
6/6/2001
Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Syste ...
Systemic Lupus Erythematosus
Drug: anti-thymocyte globulin;Drug: cyclophosphamide;Drug: filgrastim;Procedure:
CD34+ Peripheral Blood Stem Cell Reinfusion
Drug: anti-thymocyte globulin;Drug: cyclophosphamide;Drug: filgrastim;Procedure:
CD34+ Peripheral Bl
...
Northwestern Memorial Hospital
NULL
Active, not recruiting
N/A
59 Years
Both
10
Phase 1
United States